Financials
Financial year 2025
BIOLINE EUROPE from Oostkamp, company number BE0458156140, closed financial year 2025 with a result of € 38,518 after tax. For that financial year BIOLINE EUROPE recorded a gross margin of € 22,959 and equity of € 486,959. Compared with financial year 2024, the result moved from € 52,948 to € 38,518. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.
€ 486,959
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,518
▼ 27% vs 2024
Profit after tax over the fiscal year.
€ 679
▼ 98% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 362,959.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 520
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -2,398 | € -1,523 | € 38,816 | € 22,959 | ▼ 41% |
| Profit after taxes | € -3,135 | € 345 | € 52,948 | € 38,518 | ▼ 27% |
| Equity | € 395,148 | € 395,493 | € 448,441 | € 486,959 | ▲ 9% |
| Total debts | € 794 | € 643 | € 1,792 | € 4,230 | ▲ 136% |
| Cash | € 395,197 | € 19,964 | € 43,692 | € 679 | ▼ 98% |
| Retained profit | € 271,148 | € 271,493 | € 324,441 | € 362,959 | ▲ 12% |
| Balance sheet total | € 395,941 | € 396,136 | € 450,233 | € 491,189 | ▲ 9% |
Key figures of BIOLINE EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOLINE EUROPE?
What happened at BIOLINE EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Peter DOSSCHE stepped down as director. NBB
- Frederik DOSSCHE stepped down as director. NBB
- Filip DOSSCHE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 38,518 (▼ 27% vs 2024). Source: NBB ↗
- Peter DOSSCHE became a director. NBB
- Frederik DOSSCHE became a director. NBB
- Filip DOSSCHE became a director. NBB
- New establishment in Oostkamp. KBO
In short
From € 3,135 loss in 2022 to € 38,518 profit in 2025.
Best year ever: 2024, with € 52,948 profit.
Management
Directors
According to the 2025 annual accounts
Peter DOSSCHE
Managing director
Also active at: DEBAERE, SD-systems, FOOD FOR FREEDOM, PETER DOSSCHE & C°, EXKI, BIO BERRIES, O'BIO
since 2025 · until 2031
Frederik DOSSCHE
Managing director
Also active at: Oude Abdij van Drongen, DEBAERE, FOOD FOR FREEDOM, FREDERIK EN ISABELLE DOSSCHE MANAGEMENT, DST ESTATE, KENGANI, VLEESBEDRIJF D'HULSTER, FUTURE FOODS +4 more
since 2025 · until 2031
Filip DOSSCHE
Managing director
Also active at: Demival, Werkplaats voor Aangepaste Arbeid te Deinze, DEBAERE, Filip DOSSCHE & C°, PETER DOSSCHE & C°
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
De Leiteweg 28
8020 Oostkamp
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0458.156.140
- VAT number
- BE 0458.156.140
- Registered office
- De Leiteweg 28, 8020 Oostkamp
- Names & denominations
- BIOLINE EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 June 1996
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Groothandel in vlees en vleesproducten, uitgezonderd vlees van wild en van gevogelte
Groothandel in vlees en vleeswaren, exclusief vlees van gevogelte en van wild
Groothandel in groenten en fruit, muv consumptieaardappelen
Groothandel in zuivelproducten en eieren
Groothandel in zuivelproducten, eieren, spijsoliën en -vetten
Groothandel in groenten en fruit